PRESS RELEASE published on 01/16/2025 at 07:46, 1 year 3 months ago EQS-Adhoc: FRIEDRICH VORWERK will generate revenues of over €495 million in the 2024 financial year with an EBITDA margin of around 16% according to initial projections, thus significantly exceeding the forecast FRIEDRICH VORWERK surpasses revenue projections with over €495 million in 2024, achieving 16% EBITDA margin, exceeding forecasts. Strong Q4 performance boosts earnings EBITDA Margin Financial Year Forecasts Revenue Projections Friedrich Vorwerk
PRESS RELEASE published on 01/16/2025 at 07:30, 1 year 3 months ago Mutares has completed the acquisition of the assets of S.M.A. Metalltechnik GmbH & Co. KG and its subsidiaries Mutares completes acquisition of S.M.A. Metalltechnik GmbH & Co. KG assets, adding to SFC Group with expected revenues of ca. EUR 160 million in 2025 Acquisition Revenue Automotive Mutares S.M.A. Metalltechnik GmbH
PRESS RELEASE published on 01/16/2025 at 07:30, 1 year 3 months ago Klea Holding clôture l'année 2024 (+24% de croissance) avec un chiffre d'affaires trimestriel record et une amélioration de la dynamique de croissance au 4ème trimestre (+33%) Klea Holding présente les performances trimestrielles et annuelles de sa filiale Smart Salem, réseau de services médicaux digitalisés à Dubaï. Croissance significative au T4 2024 malgré les tempêtes Croissance Dubai Performances Smart Salem Klea Holding
PRESS RELEASE published on 01/16/2025 at 07:30, 1 year 3 months ago Klea Holding closes 2024 (+24% growth) with a record quarterly sales and improvement in growth momentum in Q4 (+33%) KLEA HOLDING reports record growth for Smart Salem in Q4 2024 and FY 2024, with impressive momentum in Medical Fitness and Health & Wellness segments Growth Smart Salem Klea Holding Q4 2024 Medical Services
PRESS RELEASE published on 01/16/2025 at 07:15, 1 year 3 months ago Sales growth despite strong decline in market environment Geberit AG reports 2.5% sales growth in 2024 despite challenging market conditions. EBITDA margin expected slightly lower than previous year. Full-year financial statements releasing on 6 March 2025 Financial Statements EBITDA Margin Sales Growth Market Environment Geberit AG
PRESS RELEASE published on 01/16/2025 at 07:00, 1 year 3 months ago Trading update - All mid-term targets achieved ahead of schedule ARYZTA AG achieves all mid-term targets ahead of schedule. Read the trading update for more details Trading Update SIX Swiss Exchange ARYZTA AG Mid-term Targets Achievements
PRESS RELEASE published on 01/16/2025 at 07:00, 1 year 3 months ago Helvetia Group scores highly in Top Employer ranking Helvetia Group achieves high scores in Top Employer ranking, recognized for outstanding workplace conditions and development opportunities. Full marks in AI category Helvetia Group Development Opportunities Top Employer Ranking Workplace Conditions AI Category
REGULATED PRESS RELEASE published on 01/16/2025 at 07:00, 1 year 3 months ago OPmobility fait évoluer son Comité de Direction pour accélérer la transformation du Groupe OPmobility annonce des changements au sein de son Comité de Direction pour optimiser ses performances et offrir des solutions intégrées. Christian Kopp, Gérald Mentil et Hélène Dantoine prennent de nouvelles fonctions Performance Changement Comité De Direction Intégration OPmobility
REGULATED PRESS RELEASE published on 01/16/2025 at 07:00, 1 year 3 months ago OPmobility makes changes to its Executive Committee to accelerate the Group's transformation OPmobility announces changes to its Executive Committee to accelerate the Group's transformation for providing integrated solutions and optimizing operational performance Executive Committee Operational Performance Transformation OPmobility Integrated Solutions
PRESS RELEASE published on 01/16/2025 at 07:00, 1 year 3 months ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital Innate Pharma publie le nouveau nombre d'actions et de droits de vote au 31 décembre 2024 conformément à la réglementation financière. Détails sur son capital social et ses projets d'immunothérapie contre le cancer Droits De Vote Actions Immunothérapie Cancer Innate Pharma
Published on 04/23/2026 at 14:30, 24 minutes ago Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage
Published on 04/23/2026 at 14:30, 24 minutes ago Hillcrest Energy Technologies Finalizes A-Sample Design of ZVS PCS1000 Sidecar Power Unit for Next-Generation AI Data Centers
Published on 04/23/2026 at 14:00, 54 minutes ago Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Published on 04/23/2026 at 14:00, 54 minutes ago GameSquare's Stream Hatchet Publishes Q1 2026 Live Streaming Trends Report
Published on 04/23/2026 at 14:05, 49 minutes ago FERROSA THERAPEUTICS ANNOUNCES SEED FINANCING TO ADVANCE A FIRST-IN-CLASS BISPECIFIC ANTIBODY PROGRAM FOR ANEMIA OF INFLAMMATION
Published on 04/23/2026 at 14:00, 54 minutes ago CorTec’s Brain Interchange™ Accepted into FDA Total Product Life Cycle Advisory Program (TAP)
Published on 04/23/2026 at 14:00, 54 minutes ago Immunic, Inc. Announces 1-for-10 Reverse Stock Split
Published on 04/23/2026 at 13:43, 1 hour 11 minutes ago clearvise optimizes portfolio by capitalizing on favorable market conditions: Successful sale of small-scale PV division
Published on 04/23/2026 at 14:30, 24 minutes ago KURMA PARTNERS, AN EURAZEO GROUP COMPANY, CLOSES €215 MILLION BIOFUND IV
Published on 04/23/2026 at 14:30, 24 minutes ago KURMA PARTNERS, MEMBRE DU GROUPE EURAZEO, ANNONCE LE CLOSING FINAL DE SON NOUVEAU FONDS BIOFUND IV A 215 MILLIONS D’EUROS
Published on 04/23/2026 at 14:18, 36 minutes ago CP Mise à disposition du rapport financier annuel 2025
Published on 04/23/2026 at 09:40, 5 hours 13 minutes ago Mise à disposition du Document d’Enregistrement Universel 2025
Published on 04/23/2026 at 08:15, 6 hours 39 minutes ago STEF : Chiffre d'affaires consolidé du 1er trimestre 2026